Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Justin AC Powell
    Junior Member
    • Jun 2012
    • 5

    #1

    RNA-Seq quantitation for human, paired end vs single end, strand specific or not?

    Is there any consensus of opinion on the best RNA-Seq approach for quantitation of alternative splicing on well annotated genomes (e.g. human)? We don’t want to look for novel splice isoforms, we want to detect regulation of alternative splicing by our treatment among the annotated isoforms of a gene. For roughly the same price I can get:

    60M x 50 bp single end reads

    30M x 50bp paired end reads random primed cDNA

    30M x 125 bp paired end reads using strand specific cDNA library

    I guess in part this depends on the differential splicing analysis method chosen – something that counts only exon inclusion should work just as well with single ends. If you look for exon exclusion then you need reads that map across splice junctions, I don’t know if the chances of that are improved more by increasing the read length, or increasing the read depth (naively it would seem doubling either would have the same effect). Finally I don’t know what the benefit of strand specific libraries are for quantitation, one concern is that if they are more involved to produce then they might introduce variability - obviously in some cases they will help discriminate between sense and anti-sense transcripts from the same region.
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    'Of a gene'? A specific gene? How highly expressed?

    Ever considered the Iso-Seq PacBio protocol?

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      For reference (cross-posted): https://www.biostars.org/p/173399/

      Comment

      • Justin AC Powell
        Junior Member
        • Jun 2012
        • 5

        #4
        It's exploratory - so we're looking genome wide. Our vendor doesn't seem to recommend Iso-Seq for differential RNA expression but I haven't discussed why.

        Comment

        • danwiththeplan
          Member
          • Sep 2011
          • 72

          #5
          While trinity is obviously not relevant for humans, this vid explains strand specficity quite well:



          You will likely miss antisense transcription without it, or worse, mistake it for sense transcription, which could cause issues resolving isoforms?

          Comment

          • gringer
            David Eccles (gringer)
            • May 2011
            • 845

            #6
            No eukaryote genome is sufficiently annotated that novel isoforms won't be found in RNASeq data. Even if that were the case, some genes have fairly complex splice variants that benefit a lot from strand-specific sequencing. As an example, the transcriptome annotation shows genes that overlap with another gene on the opposite strand, and resolution of these genes will be impossible without strand-specific sequencing.

            Regardless, given the choice between "60M x 50 bp single end" and "30M x 125 bp anything", I would choose the longer reads. Even if it were single end, you're getting a higher coverage with the longer reads (60 * 50 vs 30 * 125).

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            55 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            40 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            46 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            46 views
            0 reactions
            Last Post SEQadmin2  
            Working...